Sutro Biopharma, Inc.STRONASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-194.64M
↓ 191% below average
Average (8y)
$-66.90M
Historical baseline
Range
High:$11.13M
Low:$-194.64M
CAGR
+35.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-194.64M | -67.9% |
| 2023 | $-115.93M | -2590.4% |
| 2022 | $-4.31M | +95.6% |
| 2021 | $-97.00M | -29.5% |
| 2020 | $-74.93M | -9.4% |
| 2019 | $-68.50M | -715.7% |
| 2018 | $11.13M | +127.5% |
| 2017 | $-40.39M | -130.2% |
| 2016 | $-17.55M | - |